These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32753708)

  • 1. Adverse neonatal outcomes associated with maternal severe mental health diagnoses and opioid use.
    Ma J; Sahasranaman V; Kirby RS; Boaz T
    J Perinatol; 2020 Oct; 40(10):1497-1505. PubMed ID: 32753708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
    Kaltenbach K; Holbrook AM; Coyle MG; Heil SH; Salisbury AL; Stine SM; Martin PR; Jones HE
    Addiction; 2012 Nov; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
    Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
    Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.
    Sujan A; Cleary E; Douglas E; Aujla R; Boyars L; Smith C; Guille C
    Fam Pract; 2022 Mar; 39(2):311-315. PubMed ID: 34537839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine: a new player in neonatal withdrawal syndrome.
    Nanda S; Brant R; Regier M; Yossuck P
    W V Med J; 2015; 111(1):16-21. PubMed ID: 25665273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
    Nechanská B; Mravčík V; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Handal M
    Addiction; 2018 Jul; 113(7):1286-1294. PubMed ID: 29443414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.
    Wang S; Meador KJ; Pawasauskas J; Lewkowitz AK; Ward KE; Brothers TN; Hartzema A; Quilliam BJ; Wen X
    Drug Saf; 2023 Mar; 46(3):257-271. PubMed ID: 36642778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal abstinence syndrome after methadone or buprenorphine exposure.
    Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Fischer G
    N Engl J Med; 2010 Dec; 363(24):2320-31. PubMed ID: 21142534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.
    Pritham UA; Paul JA; Hayes MJ
    J Obstet Gynecol Neonatal Nurs; 2012 Mar; 41(2):180-190. PubMed ID: 22375882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes.
    Jones HE; Heil SH; Tuten M; Chisolm MS; Foster JM; O'Grady KE; Kaltenbach K
    Drug Alcohol Depend; 2013 Aug; 131(3):271-7. PubMed ID: 23279924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes associated with the use of medications for opioid use disorder during pregnancy.
    Krans EE; Kim JY; Chen Q; Rothenberger SD; James AE; Kelley D; Jarlenski MP
    Addiction; 2021 Dec; 116(12):3504-3514. PubMed ID: 34033170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
    Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
    J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
    Dave CV; Goodin A; Zhu Y; Winterstein A; Wang X; Alrwisan A; Hartzema A
    Pharmacotherapy; 2019 Oct; 39(10):1005-1011. PubMed ID: 31361913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between gestational age and the severity of neonatal abstinence syndrome.
    Gibson KS; Stark S; Kumar D; Bailit JL
    Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Outpatient Methadone Weaning Program by a Neonatal Intensive Care Unit for Neonatal Abstinence Syndrome.
    Lai A; Philpot P; Boucher J; Meyer A
    Popul Health Manag; 2017 Oct; 20(5):397-401. PubMed ID: 28430046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid Utilization by Pregnant Women with Sickle Cell Disease and the Risk of Neonatal Abstinence Syndrome.
    Nnoli A; Seligman NS; Dysart K; Baxter JK; Ballas SK
    J Natl Med Assoc; 2018 Apr; 110(2):163-168. PubMed ID: 29580450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
    Coyle MG; Salisbury AL; Lester BM; Jones HE; Lin H; Graf-Rohrmeister K; Fischer G
    Addiction; 2012 Nov; 107 Suppl 1(0 1):63-73. PubMed ID: 23106928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.